We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+12.8%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.21B
AUM Growth
-$296M
Cap. Flow
-$592M
Cap. Flow %
-18.42%
Top 10 Hldgs %
43.24%
Holding
304
New
89
Increased
36
Reduced
82
Closed
88

Top Buys

Rank Stock Value
1
ATAI icon
AtaiBeckley Inc
ATAI
+$25.3M
2
AGL icon
Agilon Health
AGL
+$13.5M
3
LLY icon
Eli Lilly
LLY
+$13.2M
4
PRVA icon
Privia Health
PRVA
+$12.8M
5
LNTH icon
Lantheus
LNTH
+$12.3M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$23.9M
2
VCEL icon
Vericel Corp
VCEL
+$20.8M
3
ALGN icon
Align Technology
ALGN
+$19M
4
SIBN icon
SI-BONE Inc
SIBN
+$17.5M
5
STAA icon
STAAR Surgical
STAA
+$14.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.64%
2 Industrials 1.41%
3 Materials 0.54%
4 Financials 0.48%
5 Consumer Staples 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
276
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
– –
-1,650,000
Closed -$224M
ZBH icon
277
CALL
Zimmer Biomet
ZBH
$18.4B
– –
-51,294
Closed -$7.97M
IRD
278
Opus Genetics
IRD
$315M
– –
-57,536
Closed -$334K
NARI
279
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-85,000
Closed -$9.1M
DMTK
280
DELISTED
DermTech, Inc. Common Stock
DMTK
– –
-245,306
Closed -$12.5M
ALPN
281
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-131,981
Closed -$1.4M
SNCE
282
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
– –
-21,906
Closed -$4.44M
NVTA
283
PUT
DELISTED
Invitae Corporation
NVTA
– –
-50,000
Closed -$1.91M
VAPO
284
PUT
DELISTED
Vapotherm, Inc. Common Stock
VAPO
– –
-3,725
Closed -$716K
CANO
285
DELISTED
Cano Health, Inc.
CANO
– –
-10,475
Closed -$13.9M
ACGN
286
CALL
DELISTED
Aceragen Inc
ACGN
– –
-9,421
Closed -$208K
ACGN
287
PUT
DELISTED
Aceragen Inc
ACGN
– –
-19,655
Closed -$434K
HGEN
288
CALL
DELISTED
HUMANIGEN, INC.
HGEN
– –
-245,300
Closed -$4.68M
HGEN
289
PUT
DELISTED
HUMANIGEN, INC.
HGEN
– –
-340,200
Closed -$6.5M
ONCR
290
DELISTED
Oncorus, Inc.
ONCR
– –
-101,264
Closed -$1.41M
SGFY
291
DELISTED
Signify Health, Inc.
SGFY
– –
-345,757
Closed -$10.1M
EAR
292
PUT
DELISTED
Eargo, Inc. Common Stock
EAR
– –
-15,240
Closed -$15.2M
HCIIU
293
DELISTED
Hudson Executive Investment Corp. II Unit
HCIIU
– –
-150,000
Closed -$1.47M
HIIIU
294
DELISTED
Hudson Executive Investment Corp. III Unit
HIIIU
– –
-150,000
Closed -$1.49M
AGTC
295
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-206,423
Closed -$1.05M
CFMS
296
DELISTED
Conformis, Inc. Common Stock
CFMS
– –
-135,842
Closed -$3.36M
OCDX
297
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
– –
-413,891
Closed -$7.99M
XENT
298
CALL
DELISTED
Intersect ENT, Inc
XENT
– –
-256,800
Closed -$5.36M
KRA
299
CALL
DELISTED
Kraton Corporation
KRA
– –
-202,500
Closed -$7.41M
SOLY
300
DELISTED
Soliton, Inc.
SOLY
– –
-237,650
Closed -$4.18M
9 10 11
12
13

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2021 Portfolio in Review

As of Q2 2021, Pura Vida Investments held 304 positions worth $3.21B, down 8.4% from $3.51B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments withdrew a net $592M in Q2 2021, closing 88 positions and reducing 82 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $23.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.

Against the trend, Pura Vida Investments opened a new position in AtaiBeckley Inc worth $23.2M.

  • Pura Vida Investments's largest Q2 2021 buy was AtaiBeckley Inc: 1,371,824 shares worth $23.2M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q2 2021, an estimated $9.15M increase.
  • Pura Vida Investments's biggest Q2 2021 reduction was STAAR Surgical, cutting an estimated $14.6M.
  • Pura Vida Investments fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $23.9M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $3.21B portfolio in Q2 2021.
  • Pura Vida Investments opened 89 new positions and closed 88 in Q2 2021.
  • Pura Vida Investments's portfolio value fell 8.4% quarter-over-quarter to $3.21B.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.